<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0398367" disease_type="Disease or Syndrome" abbrv="">Kikuchi-Fujimoto disease</z:e> is a form of reactive <z:hpo ids='HP_0002716'>lymphadenopathy</z:hpo>, which was firstly described in Japan, but is uncommon in the Western world </plain></SENT>
<SENT sid="1" pm="."><plain>We retrospectively reviewed the medical records of nine cases of adult or adolescent <z:e sem="disease" ids="C0398367" disease_type="Disease or Syndrome" abbrv="">Kikuchi's disease</z:e> diagnosed in a single Haematology Unit in Athens, Greece between 1990 and 2006 </plain></SENT>
<SENT sid="2" pm="."><plain>The median age of the patients was 25 years (14-40) and 8/9 were females </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients presented with cervical <z:hpo ids='HP_0002716'>lymphadenopathy</z:hpo> sparing the supraclavicular fossa; one had associated axillary <z:hpo ids='HP_0002716'>lymphadenopathy</z:hpo>, seven had <z:hpo ids='HP_0001945'>fever</z:hpo> and two were asymptomatic </plain></SENT>
<SENT sid="4" pm="."><plain>The median duration of <z:hpo ids='HP_0002716'>lymphadenopathy</z:hpo> before presentation was 30 days (10-45) </plain></SENT>
<SENT sid="5" pm="."><plain>Just palpable <z:hpo ids='HP_0001744'>splenomegaly</z:hpo> was recorded in three patients </plain></SENT>
<SENT sid="6" pm="."><plain>The median value of the maximal lymph node diameter was 2 cm (1-5) and only 1/9 had nodes &gt;2 cm in their largest diameter </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0002716'>Lymphadenopathy</z:hpo> was tender in two patients; hard nodes were observed in three patients </plain></SENT>
<SENT sid="8" pm="."><plain>The median leukocyte count was 4.7 x 10(9)/l (2.2-4.9) with a <z:mpath ids='MPATH_458'>normal</z:mpath> differential in 7/9 patients </plain></SENT>
<SENT sid="9" pm="."><plain>No infectious agent could be demonstrated </plain></SENT>
<SENT sid="10" pm="."><plain>One patient had clinical and laboratory evidence of <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> (APLS) </plain></SENT>
<SENT sid="11" pm="."><plain>In conclusion, <z:e sem="disease" ids="C0398367" disease_type="Disease or Syndrome" abbrv="">Kikuchi's disease</z:e> represents a rare but important diagnostic possibility for patients presenting with <z:hpo ids='HP_0002716'>lymphadenopathy</z:hpo> in Greece and other western countries </plain></SENT>
<SENT sid="12" pm="."><plain>In this setting, <z:hpo ids='HP_0002960'>autoimmune disorders</z:hpo>, mainly <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> and APLS, should be considered and excluded by the appropriate laboratory work-up </plain></SENT>
</text></document>